Meissa Vaccines, Inc.

White House officials have high expectations for the next generation of COVID-19 vaccines, a bar that may prove difficult to meet. Shifting market dynamics and a less hospitable research environment a

Achilles Raises £100m In Series B Round Cancer immunotherapy company Achilles Therapeutics Ltd. raised £100m ($121m) in its Series B round. RA Capital led and was joined by founding investor Syncona

Frequent biopharmaceutical company backer Deerfield Management Co. LP is investing $635m in a New York City life science campus with $540m in financing from Blackstone Real Estate and others to buy an

The 2011 start-up Arteaus Therapeutics LLC , funded by Atlas Venture and OrbiMed, has generated a return more than 16 times the original $18m the venture capital firms invested in the company now tha